If you are also using a semaglutide protocol alongside tirzepatide, or recently switched between the two medications , make sure your documentation reflects which medication you are currently taking
Wegovy has been approved by the FDA to reduce risk of major adverse cardiovascular events (MACE) in those with a history of MACE, but studies of Zepbound are still pending
Inform patients that the risk of hypoglycemia is increased when tirzepatide is used with an insulin secretagogue (such as a sulfonylurea) or insulin
While some compounding pharmacies may still carry them, most patients will have to rely on autopen devices, which provide higher doses than typically used in ME/CFS, or vials
PubMed evidence trail Research sources used to frame this page For Eden Health vs Fridays: GLP-1 Program Comparison 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available
Zepbound's evidence in weight and sleep apnea Tirzepatide, Zepbound's active molecule, was studied for weight management in the SURMOUNT program (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024) examined obstructive sleep apnea outcomes
.webp)
